Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Toxoplasma gondii | thioredoxin reductase | 0.0047 | 0.044 | 1 |
Plasmodium falciparum | importin beta, putative | 0.0029 | 0.0166 | 0.2921 |
Schistosoma mansoni | ran | 0.0021 | 0.0053 | 0.0053 |
Mycobacterium tuberculosis | Putative ferredoxin reductase | 0.0107 | 0.1341 | 0.8342 |
Brugia malayi | Thioredoxin reductase | 0.0047 | 0.044 | 0.1254 |
Schistosoma mansoni | importin beta-1 | 0.0029 | 0.0166 | 0.0166 |
Mycobacterium leprae | DIHYDROLIPOAMIDE DEHYDROGENASE LPD (LIPOAMIDE REDUCTASE (NADH)) (LIPOYL DEHYDROGENASE) (DIHYDROLIPOYL DEHYDROGENASE) (DIAPHORASE | 0.0119 | 0.152 | 1 |
Brugia malayi | photoreceptor-specific nuclear receptor | 0.0252 | 0.3511 | 1 |
Echinococcus granulosus | GTP binding nuclear protein Ran | 0.0021 | 0.0053 | 0.0053 |
Schistosoma mansoni | hypothetical protein | 0.0305 | 0.4315 | 0.4315 |
Trichomonas vaginalis | importin beta-1, putative | 0.0023 | 0.0085 | 1 |
Echinococcus multilocularis | snurportin 1 | 0.0305 | 0.4315 | 0.4315 |
Schistosoma mansoni | microtubule-associated protein tau | 0.0684 | 1 | 1 |
Mycobacterium tuberculosis | Probable nitrite reductase [NAD(P)H] large subunit [FAD flavoprotein] NirB | 0.0107 | 0.1341 | 0.8342 |
Plasmodium vivax | thioredoxin reductase, putative | 0.0047 | 0.044 | 1 |
Onchocerca volvulus | Steroid hormone receptor family member cnr14 homolog | 0.0018 | 0 | 0.5 |
Echinococcus multilocularis | microtubule associated protein 2 | 0.0684 | 1 | 1 |
Giardia lamblia | GTP-binding nuclear protein RAN/TC4 | 0.0021 | 0.0053 | 0.5 |
Plasmodium falciparum | glutathione reductase | 0.0047 | 0.044 | 1 |
Echinococcus multilocularis | thioredoxin glutathione reductase | 0.0047 | 0.044 | 0.044 |
Trichomonas vaginalis | Importin beta-1 subunit, putative | 0.0023 | 0.0085 | 1 |
Mycobacterium tuberculosis | Probable membrane NADH dehydrogenase NdhA | 0.0107 | 0.1341 | 0.8342 |
Loa Loa (eye worm) | hypothetical protein | 0.0029 | 0.0166 | 0.0384 |
Echinococcus multilocularis | nuclear receptor co repressor related (ncor) | 0.0273 | 0.3835 | 0.3835 |
Trypanosoma brucei | importin beta-1 subunit, putative | 0.0029 | 0.0166 | 0.2921 |
Echinococcus granulosus | geminin | 0.0168 | 0.2257 | 0.2257 |
Trypanosoma cruzi | trypanothione reductase, putative | 0.0047 | 0.044 | 1 |
Plasmodium falciparum | thioredoxin reductase | 0.0047 | 0.044 | 1 |
Brugia malayi | RNA, U transporter 1 | 0.0081 | 0.0956 | 0.2724 |
Mycobacterium tuberculosis | NAD(P)H quinone reductase LpdA | 0.0119 | 0.152 | 1 |
Loa Loa (eye worm) | GTP-binding nuclear protein RAN/TC4 | 0.0021 | 0.0053 | 0.0122 |
Mycobacterium tuberculosis | Probable dehydrogenase | 0.0107 | 0.1341 | 0.8342 |
Entamoeba histolytica | hypothetical protein | 0.0023 | 0.0085 | 1 |
Echinococcus granulosus | importin subunit beta 1 | 0.0029 | 0.0166 | 0.0166 |
Loa Loa (eye worm) | hypothetical protein | 0.0252 | 0.3511 | 0.8136 |
Plasmodium vivax | importin-beta 2, putative | 0.0029 | 0.0166 | 0.2921 |
Mycobacterium tuberculosis | Dihydrolipoamide dehydrogenase LpdC (lipoamide reductase (NADH)) (lipoyl dehydrogenase) (dihydrolipoyl dehydrogenase) (diaphoras | 0.0119 | 0.152 | 1 |
Plasmodium vivax | glutathione reductase, putative | 0.0047 | 0.044 | 1 |
Schistosoma mansoni | hypothetical protein | 0.0168 | 0.2257 | 0.2257 |
Leishmania major | trypanothione reductase | 0.0047 | 0.044 | 1 |
Brugia malayi | GTP-binding nuclear protein RAN/TC4 | 0.0021 | 0.0053 | 0.015 |
Onchocerca volvulus | Protein ultraspiracle homolog | 0.0018 | 0 | 0.5 |
Trypanosoma brucei | importin beta-1 subunit, putative | 0.0029 | 0.0166 | 0.2921 |
Brugia malayi | glutathione reductase | 0.0047 | 0.044 | 0.1254 |
Mycobacterium tuberculosis | Probable NADH dehydrogenase Ndh | 0.0107 | 0.1341 | 0.8342 |
Echinococcus granulosus | thioredoxin glutathione reductase | 0.0047 | 0.044 | 0.044 |
Echinococcus multilocularis | GTP binding nuclear protein Ran | 0.0021 | 0.0053 | 0.0053 |
Echinococcus granulosus | snurportin 1 | 0.0305 | 0.4315 | 0.4315 |
Mycobacterium tuberculosis | Probable oxidoreductase | 0.0119 | 0.152 | 1 |
Echinococcus granulosus | nuclear receptor co repressor related ncor | 0.0273 | 0.3835 | 0.3835 |
Trypanosoma brucei | trypanothione reductase | 0.0047 | 0.044 | 1 |
Schistosoma mansoni | hypothetical protein | 0.0168 | 0.2257 | 0.2257 |
Trichomonas vaginalis | Importin beta-1 subunit, putative | 0.0023 | 0.0085 | 1 |
Loa Loa (eye worm) | thioredoxin reductase | 0.0047 | 0.044 | 0.102 |
Schistosoma mansoni | ran | 0.0021 | 0.0053 | 0.0053 |
Mycobacterium tuberculosis | Probable reductase | 0.0107 | 0.1341 | 0.8342 |
Echinococcus multilocularis | geminin | 0.0168 | 0.2257 | 0.2257 |
Leishmania major | importin beta-1 subunit, putative | 0.0023 | 0.0085 | 0.0829 |
Onchocerca volvulus | 0.0018 | 0 | 0.5 | |
Echinococcus multilocularis | importin subunit beta 1 | 0.0029 | 0.0166 | 0.0166 |
Trypanosoma cruzi | importin beta-1 subunit, putative | 0.0023 | 0.0085 | 0.0829 |
Loa Loa (eye worm) | nucleolar RNA-associated protein alpha | 0.0305 | 0.4315 | 1 |
Brugia malayi | Importin beta-1 subunit | 0.0029 | 0.0166 | 0.0472 |
Toxoplasma gondii | HEAT repeat-containing protein | 0.0029 | 0.0166 | 0.2921 |
Loa Loa (eye worm) | glutathione reductase | 0.0047 | 0.044 | 0.102 |
Onchocerca volvulus | Bile acid receptor homolog | 0.0018 | 0 | 0.5 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Inhibition (functional) | = 6 % | GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 LDH activity, using an LDH reporter assay. Test compounds present at 2uM | ChEMBL. | 20485427 |
Inhibition (functional) | = 19.75 % | ST_JUDE_LEISH: Cytotoxicity at 2uM final concentration against transgenic Leishmania Mexicana promastigotes LmGT2 that are glucose transport deficient and complemented with the L. Mexicana glucose transporter 2. Activity is measured by by DNA content using SYBR green in vitro | ChEMBL. | No reference |
Inhibition (functional) | = 25.77 % | ST_JUDE_LEISH: Cytotoxicity at 2uM final concentration against transgenic Leishmania Mexicana promastigotes LmGLUT1 that are glucose transport deficient and complemented with the human glucose transporter GLUT1. Activity is measured by DNA content using SYBR green in vitro | ChEMBL. | No reference |
Inhibition (functional) | = 30.77 % | ST_JUDE_LEISH: Cytotoxicity at 2uM final concentration against transgenic Leishmania Mexicana promastigotes LmPfHT that are glucose transport deficient and complemented with the Plasmodium falciparum hexose transporter. Activity is measured by by DNA content using SYBR green in vitro | ChEMBL. | No reference |
Inhibition (functional) | = 41 % | GSK_TCMDC: Percent inhibition of human HepG2 cell line. Test compounds present at 10uM. | ChEMBL. | 20485427 |
Inhibition (functional) | = 54 % | GSK_TCMDC: Inhibition of Plasmodium falciparum Dd2 in whole red blood cells, using parasite LDH activity as an index of growth. Test compounds present at 2uM | ChEMBL. | 20485427 |
Inhibition (functional) | = 100 % | GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 in whole red blood cells, using parasite LDH activity as an index of growth. Test compounds present at 2uM | ChEMBL. | 20485427 |
Inhibition frequency index (IFI) (functional) | = 2.82 | Inhibition Frequency Index (IFI) | GSK. | 20485427 |
Percent growth inhibition (functional) | = 6 % | Percent inhibition of P. falciparum lactate dehydrogenase activity (at 2 uM) | GSK. | 20485427 |
Percent growth inhibition (functional) | = 41 % | Percent inhibition of HepG2 growth (at 10 uM) | GSK. | 20485427 |
Percent growth inhibition (functional) | = 54 % | Percent inhibition of P. falciparum Dd2 growth (at 2 uM) | GSK. | 20485427 |
Percent growth inhibition (functional) | = 100 % | Percent inhibition of P. falciparum 3D7 growth (at 2 uM) | GSK. | 20485427 |
XC50 (functional) | = 6.07 | XC50 determination of P. falciparum 3D7 growth | GSK. | 20485427 |
XC50 (functional) | = 0.85904 uM | GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 in whole erythrocytes, using parasite LDH activity as an index of growth. | ChEMBL. | 20485427 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.